Departamento de Medicina, Universidad de Santiago de Compostela and Servicio de Cardiología, Complejo Hospitalario Universitario de Santiago de Compostela, Coruña, Spain.
Diabetes Metab Res Rev. 2010 Oct;26(7):550-8. doi: 10.1002/dmrr.1117.
Hyperglycaemia induces non-enzymatic glycation reactions in proteins which generate Amadori products and advanced glycation end-products; the latter are thought to participate in the vascular complications of diabetic patients. However, the exact mechanisms concerning the effects of glycated proteins on vascular tissue remain to be determined. Therefore, the effects of glycated human serum albumin on human umbilical vein endothelial cells were studied.
Reactive oxygen species production was measured by the cytochrome C reduction method and by 5(6)-carboxy-2',7'-dichlorofluorescein diacetate (c-DCF-DA) fluorescence after treating human umbilical vein endothelial cells with glycated human serum albumin (6-200 µg/mL). The expression of Nox4 and p22phox mRNAs were analysed by reverse transcription-quantitative polymerase chain reactions and the levels of their proteins were measured by immunofluorescence.
Low concentrations of glycated human serum albumin enhanced reactive oxygen species production in human umbilical vein endothelial cells after 4 h of treatment at both extracellular and intracellular sites. This enhanced production was sustained, although to a lesser extent, after 6 and 12 h of treatment. The gene expression study revealed that Nox4 and p22phox mRNA levels were elevated after 4 h of treatment with glycated human serum albumin. This mRNA elevation and enhanced reactive oxygen species production correlated with an increased expression of the Nox4 protein.
The results revealed that a circulating and abundant modified glycated human serum albumin protein in diabetic patients induced a sustained reactive oxygen species production in human endothelial cells. This effect may have been due to an up-regulation of Nox4, the main subunit of NADPH oxidase in the endothelium.
高血糖会诱导蛋白质发生非酶糖基化反应,生成麦拉德产物和晚期糖基化终产物;后者被认为参与了糖尿病患者的血管并发症。然而,糖基化蛋白对血管组织的确切影响机制仍有待确定。因此,研究了糖化人血清白蛋白对人脐静脉内皮细胞的影响。
用细胞色素 C 还原法和 5(6)-羧基-2',7'-二氯荧光素二乙酸酯(c-DCF-DA)荧光法测量糖化人血清白蛋白(6-200 µg/mL)处理人脐静脉内皮细胞后活性氧的产生。通过逆转录定量聚合酶链反应分析 Nox4 和 p22phox mRNA 的表达,并通过免疫荧光法测量其蛋白水平。
低浓度的糖化人血清白蛋白在细胞外和细胞内部位处理 4 小时后,增强了人脐静脉内皮细胞内的活性氧产生。这种增强的产生在 6 和 12 小时的处理后持续存在,尽管程度较小。基因表达研究表明,糖化人血清白蛋白处理 4 小时后,Nox4 和 p22phox mRNA 水平升高。这种 mRNA 升高和活性氧产生的增强与 Nox4 蛋白的表达增加相关。
结果表明,糖尿病患者循环中丰富的修饰糖化人血清白蛋白蛋白诱导了人内皮细胞中持续的活性氧产生。这种效应可能是由于内皮细胞中 NADPH 氧化酶的主要亚基 Nox4 的上调所致。